0001562180-23-006456.txt : 20230818
0001562180-23-006456.hdr.sgml : 20230818
20230818191346
ACCESSION NUMBER: 0001562180-23-006456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOORE JOHN R
CENTRAL INDEX KEY: 0001191702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 231187036
MAIL ADDRESS:
STREET 1: 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-08-17
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001191702
MOORE JOHN R
C/O EDGEWISE THERAPEUTICS, INC.
1715 38TH ST
BOULDER
CO
80301
false
true
false
false
General Counsel
false
Stock Option (Right to Buy)
7.08
2023-08-17
4
A
false
200000.00
0.00
A
2033-08-17
Common Stock
200000.00
200000.00
D
1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date.
/s/ John R. Moore
2023-08-18